Multicenter, prospective, and non-randomized investigation on efficacy and safety of a newly designed treatment protocol for newly diagnosed acute promyelocytic leukemia patients

Trial Profile

Multicenter, prospective, and non-randomized investigation on efficacy and safety of a newly designed treatment protocol for newly diagnosed acute promyelocytic leukemia patients

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2016

At a glance

  • Drugs Arsenic trioxide (Primary) ; Tretinoin (Primary) ; Cytarabine; Daunorubicin; Mitoxantrone
  • Indications Acute promyelocytic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2016 Status changed from not yet recruiting to completed.
    • 19 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top